|
Research reports (papers
and reviews) within recent
5 years
|
- Minagawa H, Hashimoto K, Yanagi Y. Absence of tumour necrosis factor
facilitates primary and recurrent herpes simplex virus-1 infections.J Gen Virol. 2004 Feb;85(Pt 2):343-7.
- Hashimoto K, Minagawa H, Yanagi Y. Caspase-dependent apoptosis in fulminant
hepatic failure induced by herpes simplex virus in mice.J
Hepatol. 2003 Nov;39(5):773-8.
- Seki F, Ono N, Yamaguchi R, Yanagi Y. Efficient isolation of wild strains
of canine distemper virus in Vero cells expressing canine SLAM (CD150)
and their adaptability to marmoset B95a cells. J
Virol. 2003 Sep;77(18):9943-50.
- Ohno S, Seki F, Ono N, Yanagi Y. Histidine at position 61 and its adjacent
amino acid residues are critical for the ability of SLAM (CD150) to act
as a cellular receptor for measles virus.
J Gen Virol. 2003 Sep;84(Pt 9):2381-8.
- Shingai M, Ayata M, Ishida H, Matsunaga I, Katayama Y, Seya T, Tatsuo
H, Yanagi Y, Ogura H. Receptor use by vesicular stomatitis virus pseudotypes
with glycoproteins of defective variants of measles virus isolated from
brains of patients with subacute sclerosing panencephalitis. J
Gen Virol. 2003 Aug;84(Pt 8):2133-43.
- Bouche FB, Marquet-Blouin E, Yanagi Y, Steinmetz A, Muller CP. Neutralising
immunogenicity of a polyepitope antigen expressed in a transgenic food
plant: a novel antigen to protect against measles. Vaccine.
2003 May 16;21(17-18):2074-81.
- Yanagi Y, Ono N, Tatsuo H, Hashimoto K, Minagawa H. Measles virus receptor
SLAM (CD150).
Virology2002,299(2):155-161.
- Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi
Y. SLAM (CD150)-independent measles virus entry as revealed by recombinant
virus expressing green fluorescent protein. J.
Virol. 76:6743-9 (2002)
- Vincent S, Tigaud I, Schneider H, Buccholz C, Yanagi Y, Gerlier D. Restriction
of measles virus RNA synthesis by a mouse host cell line:trans-complementation
by polymerase components or a human cellular factor(s). J
Virol. 2002 Jun;76(12):6121-30.
-
Tatsuo H, Yanagi Y. The morbillivirus receptor SLAM (CD150). Microbiol
Immunol. 2002;46(3):135-142.
- Tanaka K, Minagawa H, Xie MF, Yanagi Y. The measles virus hemagglutinin
downregulates the cellular receptor SLAM (CD150). Arch
Virol.2002;147(1):195-203.
- Minagawa H, Tanaka K, Ono N, Tatsuo H, Yanagi Y. Induction of the measles
virus receptor SLAM (CD150) on monocytes. J Gen Virol 2001 Dec;82(Pt 12):2913-7
- Tatsuo.H, Ono N, Yanagi Y, Morbilliviruses Use Signaling Lymphocyte
Activation Molecules(CD150) as Cellular Receptors. J.Virol. 2001;75(13):5842-5850
- Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. Measles Viruses
on Throat Swabs from Measles Patients Use SLAM (CDw150) but Not CD46 as
a Cellular Receptor. J. Virol. 2001;75(9):4399-4401
Yanagi Y. The cellular receptor for measles virus-elusive no more. Rev.Med. Virol. 2001;11:149-156
- Okuma K, Matsuura Y, Tatsuo H, Inagaki Y, Nakamura M, Yamamoto N, Yanagi
Y. Analysis of the molecules involved in human T-cell leukemia virus
type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope
glycoproteins. J. Gen. Virol. 2001;82:821-830
- Ono N, Tatsuo H, Tanaka K, Minagawa H, Yanagi Y. V domain of human
SLAM(CDw150) is essential for its function as a measles virus receptor.
J.Virol. 2001;75:1594-1600.
- Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor
for measles virus. Nature2000;406:893-897.
- Minagawa H, Yanagi Y. Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+ T cells: A new model for latency. Arch.Virol.2000;145:2259-2272.
- Tatsuo H, Okuma K, Tanaka K, Ono N, Minagawa H, Takade A, Matsuura Y, Yanagi Y. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J. Virol. 2000; 74(9):4139-45
- Kimura Y, Hayashida K, Ishibashi H, Niho Y, Yanagi Y. Antibody-free
virion titer greatly differs between hepatitis C virus genotypes. J. Med. Virol. 2000;61(1):37-43.
|